US Stock MarketDetailed Quotes
ALNY Alnylam Pharmaceuticals
- 251.840
- +0.860+0.34%
Trading Nov 26 12:24 ET
32.48BMarket Cap-96122P/E (TTM)
252.645High247.755Low340.34KVolume249.370Open250.980Pre Close85.29MTurnover0.27%Turnover RatioLossP/E (Static)128.98MShares304.39052wk High1003.35P/B32.35BFloat Cap141.97552wk Low--Dividend TTM128.44MShs Float304.390Historical High--Div YieldTTM1.95%Amplitude3.650Historical Low250.609Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Alnylam Pharmaceuticals Stock Forum
Alnylam Highlights New Data From HELIOS-B Study of Vutrisiran for the Treatment of Transthyretin Amyloidosis With Cardiomyopathy at Heart Failure Society of America Annual Scientific Meeting 2024 | ALNY Stock News
ALNY BUY ALERT 🚨 DRUG NEWS MULTIPLE PRICE TARGET RAISES
No comment yet